Teladoc Health, Inc. (TDOC) Financials
TDOC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 4.3 billion | 2.0 billion |
2023-12-31 | 4.4 billion | 2.1 billion |
2023-09-30 | 4.3 billion | 2.0 billion |
2023-06-30 | 4.3 billion | 2.0 billion |
TDOC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | -26.6 million | 42.3 million |
2023-12-31 | 93.6 million | 46.8 million |
2023-09-30 | 68.0 million | 53.0 million |
2023-06-30 | 64.6 million | 55.7 million |
TDOC Net Income
No data available :(
TDOC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 1.1 billion | - | 50.7 million |
2023-12-31 | 1.1 billion | - | 53.6 million |
2023-09-30 | 1.0 billion | - | 34.4 million |
2023-06-30 | 958.7 million | 1.5 billion | 36.8 million |
TDOC Shares Outstanding
TDOC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 35.5 million | 81.4 million | 111.7 million | 237.7 million |
2023-12-31 | 36.5 million | 89.9 million | 95.1 million | 53.0 million |
2023-09-30 | 37.6 million | 84.3 million | 115.7 million | 186.2 million |
2023-06-30 | 36.6 million | 87.3 million | 139.7 million | 218.4 million |
TDOC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 646.1 million | 292.4 million |
2023-12-31 | 660.5 million | 193.4 million |
2023-09-30 | 660.2 million | 186.0 million |
2023-06-30 | 652.4 million | 190.5 million |
TDOC
Price: $12.78
52 week price:
Earnings Per Share: -1.34 USD
P/E Ratio: -0.82
Exchange: NYQ
Sector: Healthcare
Industry: Health Information Services
Volume: 4.6 million
Ebitda: -15.1 millionMarket Capitalization: 2.2 billion